Why the study?
Does an Atrial-flow-regulator device improve symptoms and prevent syncope in a pediatric patient with idiopathic pulmonary arterial hypertension?
Does an Atrial-flow-regulator device improve symptoms and prevent syncope in a pediatric patient with idiopathic pulmonary arterial hypertension?
Early implantation of an Atrial-flow-regulator device may be an effective and safe interventional option for pediatric patients with pulmonary arterial hypertension and recurrent syncope.
May support hypothesis generation for AFR in refractory pediatric PH with syncope; leaves open need for controlled trials before practice change.
We report the long-term effect after successfully implanting an 8 mm Atrial-flow-regulator (AFR) device in a 7-year-old girl with idiopathic pulmonary hypertension with persistent syncope under triple therapy with significant improvement after implantation and absence of any further syncope. Early Implantation of the AFR device (Occlutech, Germany) can be efficient and safe interventional therapy option for pulmonary arterial hypertension with a history of syncope.
No takes yet. Share an insight, caveat, or question.
Pattathu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: